Search

Search Constraints

You searched for: Author/Creator Marignani, Massimo

Search Results

1. A snapshot of virological presentation and outcome of immunosuppression‐driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection. Issue 7 (14th May 2019)

2. Acute fulminant hepatitis E virus genotype 3e infection: Description of the first case in Europe. (October 2014)

4. Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study. (February 2013)

5. AISF position paper on HCV in immunocompromised patients. Issue 1 (January 2019)

6. COVID-19 vaccination among cirrhotics in Italy: High coverage and effectiveness of 3 doses versus 2 in preventing breakthrough infection and hospitalization. Issue 3 (March 2023)

7. Efficacy and safety of sofosbuvir/simeprevir plus flat dose ribavirin in genotype 1 elderly cirrhotic patients: A real‐life study. (15th December 2016)

8. External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort study. Issue 6 (19th April 2018)

9. Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression. Issue 3 (28th January 2015)

10. Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression. Issue 3 (28th January 2015)